Bet on This Biotech Before Earnings

FOLD stock just pulled back to its 80-month moving average -- a historically bullish trendline

Digital Content Manager
Nov 7, 2019 at 11:41 AM
facebook twitter linkedin

Biopharmaceutical name Amicus Therapeutics, Inc. (NASDAQ:FOLD) is expected to disclose its third-quarter earnings report before the open next Monday, Nov. 11. The stock is inching higher ahead of the event, up 1.3%, at last check. What's more, a long-term sign of technical support has just emerged, too, by way of FOLD stock's 80-month moving average. 

Specifically, Amicus Therapeutics shares are within one standard deviation of their 80-month moving average, after spending a lengthy stretch north of the trendline. In fact, during the past 15 years, FOLD has made similar retreats to this trendline five other times, per data from Schaeffer's Senior Quantitative Analyst Rocky White. Three months out, FOLD was higher each time, averaging a whopping 21.35% return. At its current perch of $8.80, a similar increase would put the equity at $10.68 -- a level the stock hasn't reached since early August.

FOLD Chart Nov 7

However, it should be noted that earnings history favors the bears. In the last two years, the equity has seen only one positive next-day earnings reaction, and has averaged a 5.3% post-earnings swing, regardless of direction. This time around, the options market is pricing in an even bigger next-day move of 9.8%. 

Regardless, analyst sentiment has been quite optimistic, with 10 of the 11 in coverage calling Amicus a "strong buy." Plus, the consensus 12-month target price sits all the way up at $17.95, which is more than double FOLD's current levels, and represents a region not touched on the charts since 2015. 

Options traders have been incredibly bullish too, with an eyebrow-raising 24.5 calls purchased for every put during the past 10 days at the the International Securities Exchange (ISE), Cboe Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). This ratio stands higher than 81% of all other readings from the past year, suggesting that this heavy preference for calls is unusual. However, it should be noted that FOLD's options volume runs very light on an absolute basis.

Lastly, while short interest has started to unwind, these pessimistic positions still make up 11.8% of the stock's available float. What's more, at FOLD's average pace of trading, it would take over seven days to buy back all these bearish bets, which could put some wind at the equity's back, should even more of these shorts start to jump ship.


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 


300x250 - Banner 3 - v1